So far I believe they have defeated every lawsuit.
The lawsuits are strawmen suits designed to reign in the price when the MM's want to, in my opinion...
Some posts from the yahoo board are focused on what there is, for real, in play. At least as far as I see it too...
----------------------------------------------------------------------
It appears the trial is designed to show imetelstat is superior to the current standard of care (Jakafi) and after only 24 weeks. The trial design is a set-up for accelerated approval. Johnson and Johnson showed their cards last week and significantly reduced the estimated time to market for imetelstat. We are in extremely good hands with JNJ. The JNJ deal is Geron's saving grace.
-------------------------------------------------------------------
FDA approves Jakafi to treat patients with a chronic type of bone marrow disease
First FDA-approved drug for polycythemia vera
For Immediate Release
December 4, 2014
Jakafi is marketed by Wilmington, Delaware-based Incyte Corp.
-------------------------------------------------------------------
Incyte Corp.
focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. It offers JAKAFI, an oral janus associated kinase (JAK) inhibitor for the treatment of patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF, and post-essential thrombocythemia MF. Its product pipe line includes ruxolitinib, which is in Phase III clinical trial for pancreatic cancer; and in Phase II trial for the treatment of breast cancer
--------------------------------------------------------------------
Within 24 weeks we will know if Geron is superior to Jakafi.
If it is we should be awarded FDA approval for even just the patients that Jakafi has not helped...
That is a key part of this to get...
So we are only testing on those Patients that have not been helped by an ALREADY FDA approved drug.
How can they not approve us to help even those people..?
it is brilliant and shows what having J&J and Tefferi on board can do...
All's good in the hood as far as i see...
"evil flourishes when good people fail to act"
